In the MASAI trial of 105,934 women, AI-supported mammography screening was non-inferior to standard double reading for interval cancer (1.55 vs 1.76 per 1000; ratio 0.88, 95% CI 0.65-1.18), with higher sensitivity (80.5% vs 73.8%) and equal specificity (98.5%).
RCTn = 105,934
Gommers et al. Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial